Granted Patent
B2
US 8,268,983 · App. 12/230,913 · Granted Sep 18, 2012
Primers for amplifying and detecting the beta 2 adrenergic receptor gene
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Present invention relates to a method for predicting an individual's bronchodilatory response to a β agonist. Present invention particularly relates to the detection of specific allelic variants of the β2AR gene and their use as pharmacogenetic markers towards response to β agonist.
Claims (1)
1. A set of primers useful for the amplification and detection of the coding region of β2AR gene, wherein the set of primer comprises a forward primer consisting of SEQ ID NO: 2 and a reverse primer consisting of SEQ ID NO: 3.
Assignments (2)
CHANGE OF NAME
Recorded Jan 3, 2012
From: NICHOLAS PIRAMAL (INDIA) LIMITED
To: PIRAMAL HEALTHCARE LIMITED
Reel/Frame 027470/0124 →
CHANGE OF NAME
Recorded Jan 3, 2012
From: PIRAMAL HEALTHCARE LIMITED
To: PIRAMAL LIFE SCIENCES LIMITED
Reel/Frame 027470/0499 →
Continuity (2)